Provided by Tiger Fintech (Singapore) Pte. Ltd.

IGM Biosciences

1.08
-0.1400-11.48%
Volume:2.45M
Turnover:2.68M
Market Cap:64.92M
PE:-0.33
High:1.24
Open:1.21
Low:1.08
Close:1.22
Loading ...

IGM Biosciences Inc. Chief Business Officer Lisa Lynn Decker Reports Disposal of Common Shares

Reuters
·
21 Jun

IGM Biosciences Faces Nasdaq Non-Compliance Notice

TIPRANKS
·
12 Jun

IGM Biosciences Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with $50M Market Value Requirement

Reuters
·
12 Jun

IGM Biosciences Is Maintained at Hold by Truist Securities

Dow Jones
·
12 Jun

Analysts Offer Insights on Healthcare Companies: Merus (MRUS) and IGM Biosciences (IGMS)

TIPRANKS
·
11 Jun

Truist Cuts Price Target on IGM Biosciences to $1 From $2, Keeps Hold Rating

MT Newswires Live
·
11 Jun

IGM Biosciences Reports Increased Net Loss Amid Strategic Focus

TIPRANKS
·
03 Jun

IGM Biosciences Inc. Principal Accounting Officer Steven Weber Reports Disposal of Common Shares

Reuters
·
17 May

IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

IGM Biosciences Q1 EPS $(0.50) Misses $(0.48) Estimate, Sales $499.00K Miss $3.10M Estimate

Benzinga
·
14 May

BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination Genzyme Corp That Certain Collaboration And License Agreement

Reuters
·
09 May

IGM Biosciences Inc Says Continues to Evaluate Potential Strategic Alternatives and Reorganization Options

THOMSON REUTERS
·
09 May

IGM Biosciences Inc Says Closed Most of Remaining Lab and Office Facilities to Preserve Cash

THOMSON REUTERS
·
09 May

IGM Biosciences Inc Says on May 5, Co Received Notice of Termination Genzyme Corp That Certain Collaboration and License Agreement

THOMSON REUTERS
·
09 May

IGM Biosciences - in Connection With Agreement Termination, Co Implemented About 80% Reduction in Remaining Workforce

THOMSON REUTERS
·
09 May

IGM Biosciences Inc expected to post a loss of 41 cents a share - Earnings Preview

Reuters
·
02 May

IGM Biosciences downgraded to Underperform from Neutral at BofA

TIPRANKS
·
08 Apr

IGM Biosciences Faces Uncertainty Amid Cash Preservation and Restructuring Efforts

TIPRANKS
·
08 Mar

IGM Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
08 Mar

Morgan Stanley Sticks to Their Sell Rating for IGM Biosciences (IGMS)

TIPRANKS
·
07 Mar